MET (c-MET) FISH Probe

The c-MET FISH Probe is used to detect c-MET gene aneusomy.

Empire Genomics has developed a custom c-MET probe which can be used to detect/confirm a rearrangement of the c-MET gene. The probe comes labeled in orange and you may also choose to customize the probe to meet your needs.

The c-MET proto-oncogene encodes a transmembrane receptor tyrosine kinase (TK), the receptor for hepatocyte growth factor (HGF). Abnormal c-MET activation in cancer correlates with poor prognosis, where aberrantly active MET triggers tumor growth, formation of new blood vessels (angiogenesis) that supply the tumor with nutrients, and cancer spread to other organs (metastasis). MET is deregulated in many types of human malignancies, including cancers of kidney, liver, stomach, breast, and brain.

Germline mutations in the tyrosine kinase domain of MET occur in 100% of hereditary papillary renal cell carcinoma, and somatic mutations in MET are found in 10-15% of sporadic papillary renal cell carcinoma. Mutations in MET have been reported at low frequencies in head and neck squamous cell carcinoma, childhood hepatocellular carcinoma, NSCLC, and small cell lung cancer. Amplification of MET has been reported in gastric cancer, esophageal cancer, colorectal cancer, gliomas, clear cell ovarian cancer, and NSCLC.

Available as CE marked product in Green and Orange

Loci: 7q31